申请人:SmithKline Beecham p.l.c.
公开号:US05708174A1
公开(公告)日:1998-01-13
Compounds of formula (I), wherein formula I consists of formulae (I-1) to (I-4), which are defined in the specification, and pharmaceutically acceptable salts thereof, and the use of a compound of formula I or a pharmaceutically acceptable salt thereof, and their use as pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorder.
式(I)的化合物,其中式I由式(I-1)到(I-4)组成,这些式在说明书中有定义,以及其药用盐,以及化合物式I或其药用盐的用途,以及它们作为药物在治疗胃肠道疾病、心血管疾病和中枢神经系统疾病中的用途。